July 17, 2009

World Health Organization to Stop Tracking Swine Flu Cases

What?!

Wait... I thought that H1N1 was such a huge threat that we needed to rush out a vaccine to everyone on the planet with as little as five days of safety testing, and that HHS "anticipated" being voluntary, but could be made mandatory for everyone.

But apparently is it also so small a threat that we don't even need to track how big the threat is any more.

You have got to be kidding me.

Apparently they mentioned this little tidbit under their breath as they were leaving a room or something, because their official spokesman was baffled when someone asked him about it.

I try very hard not to become cynical on vaccine issues and rush to blame over zealous vaccination policies on motives of financial gain, but I don't know how not to go there when the agency calling for world wide swine flu uptake stops measuring the need for such uptake.

As soon as they stop counting, no one can make the arguement that this vaccine will be necessary because we won't know how many people are actually dying from it. Which is fewer and fewer, now that the number of people infected is actually in the millions.

So we are just supposed to take WHO's advice to take a minimally tested vaccine, with out knowing if it really is necessary? Knowing full well that THEY don't even know if it is necessary?

When will health policy makers begin acting in good faith with the people who are supposed to be following their polices? Because now they know that we know that they don't even know if this shot is necessary?

I just we are just supposed to turn off our brains, not think for ourselves, have no desire to make informed health decisions and hand over our cash (via taxes, insurance premiums or actual cash) and get a shot because some people we don't know with letters after their names said so.

Come to think of it, who is the WHO anyway? Who are they accountable to, what do they know about me and my family, and why do I care what they think? If they are wrong in their recommendations and policies, or even criminal, what recourse do I have? Writing a strongly worded letter?

...becoming cynical...

W.H.O. Says It Plans to Stop Tracking Swine Flu Cases
New York Times
By DONALD G. McNEIL Jr.
Published: July 16, 2009

In a move that caught many public health experts by surprise, the World Health Organization quietly announced Thursday that it would stop tracking swine flu cases and deaths around the world.
Skip to next paragraph
Related
Times Topics: Swine Flu (AH1N1 Virus) | World Health Organization

The announcement, made in a “briefing note” posted on the organization’s Web site late in the day, perplexed some experts, and even baffled a W.H.O. spokesman, Gregory Hartl, who said in an e-mail message, “I don’t have reliable info” about what his agency would track instead.

Only a little earlier in the day, Mr. Hartl had confirmed that Argentina, with 137 swine flu deaths since June, had surpassed Mexico, where the epidemic began in February, as the country with second largest number of swine flu deaths. Mexico has 121, and the United States, with a much larger population, has 211.

The last W.H.O. update, issued on July 6, showed 94,512 confirmed cases in 122 countries, with 429 deaths.

Many epidemiologists have pointed out that, in reality, millions of people have had swine flu, usually in a mild form, so the numbers of laboratory-confirmed cases were actually meaningless. And performing the tests has overwhelmed many national laboratories.

The briefing note said countries would still be asked to report their first few confirmed cases. It also said countries should watch for clusters of fatalities, which could indicate that the virus had mutated to a more lethal form. Other “signals to be vigilant for,” it said, were spikes in school absenteeism and surges in hospital visits.

July 14, 2009

Children Vaccinated for Flu at Three Times the Risk for Hospitalization than Unvaccinated Peers

...and those with asthma at a higher risk of hospitalization if they get the flu vaccine.

The American Thoracic Society: Flu Shot Not Effective in Preventing Flu-Related Hospitalizations in Asthmatic Children
News Release
FOR RELEASE MAY 19, 2009 at 1:30 p.m. PDT

FOR MORE INFORMATION, CONTACT:
Keely Savoie or Brian Kell
ksavoie@thoracic.org or bkell@thoracic.org
ATS Office: 212-315-8620 or 212-315-6442 (until May 13)
Cell phones: 917-860-5814 (KS) or 516-305-9251 (BK)
ATS Press Room: 619-525-6323, 619-525-6324 or 619-525-6325 (May 15 to 20)
Mini-Symposium time: May 19: 1:30 p.m. to 4 p.m.
Presentation time: May 19: 3:20 p.m.
Location: San Diego Convention Center, Room 3 (Upper Level)

Flu Shot Not Effective in Preventing Flu-Related Hospitalizations in Asthmatic Children

ATS 2009, SAN DIEGO— The inactivated flu vaccine does not appear to be effective in preventing influenza-related hospitalizations in children, especially the ones with asthma. In fact, children who get the flu vaccine are more at risk for hospitalization than their peers who do not get the vaccine, according to new research that will be presented on Tuesday, May 19, at the 105th International Conference of the American Thoracic Society in San Diego.

Flu vaccine (trivalent inactivated flu vaccine—TIV) has unknown effects on asthmatics.

“The concerns that vaccination maybe associated with asthma exacerbations have been disproved with multiple studies in the past, but the vaccine’s effectiveness has not been well-established,” said Avni Joshi, M.D., of the Mayo Clinic in Rochester, MN. “This study was aimed at evaluating the effectiveness of the TIV in children overall, as well as the children with asthma, to prevent influenza-related hospitalization.”

The CDC’s Advisory Committee on Immunization Practices (ACIP) and the American Academy of Pediatrics (AAP) recommend annual influenza vaccination for all children aged six months to 18 years. The National Asthma Education and Prevention Program (3rd revision) also recommends annual flu vaccination of asthmatic children older than six months.

In order to determine whether the vaccine was effective in reducing the number of
hospitalizations that all children, and especially the ones with asthma, faced over eight consecutive flu seasons, the researchers conducted a cohort study of 263 children who were evaluated at the Mayo Clinic in Minnesota from six months to 18 years of age, each of whom had had laboratory-confirmed influenza between 1996 to 2006. The investigators determined who had and had not received the flu vaccine, their asthma status and who did and did not require hospitalization. Records were reviewed for each subject with influenza-related illness for flu vaccination preceding the illness and hospitalization during that illness.

They found that children who had received the flu vaccine had three times the risk of hospitalization, as compared to children who had not received the vaccine. In asthmatic children, there was a significantly higher risk of hospitalization in subjects who received the TIV, as compared to those who did not (p= 0.006). But no other measured factors—such as insurance plans or severity of asthma—appeared to affect risk of hospitalization.

“While these findings do raise questions about the efficacy of the vaccine, they do not in fact implicate it as a cause of hospitalizations,” said Dr. Joshi. “More studies are needed to assess not only the immunogenicity, but also the efficacy of different influenza vaccines in asthmatic subjects.”

###

Session # C94: “Viral Infections in Childhood Respiratory Disease”
Abstract # 561: “Flu Vaccination in Asthmatics: Does It Work?”
http://www.call4abstracts.com/ats/society_admin/abs_preview.php?absnum=561
Close Window
ATS 2009 · San Diego
International Conference
Abstract Number: 561
Contact/Presenting Author: Avni Y. Joshi
Department/Institution: Internal Medicine, Mayo Clinic
Address: 200, First St. SW
City/State/Zip/Country: Rochester, MN, 55905
Phone: 01-507-284-2511 Fax: 01-507-284-0902 E-mail: joshi.avni@mayo.edu
ATS member: No Student or in training: Yes
Funding Source: None.
Abstract Category: 14.03 - Pediatric Asthma
Presentation format: Either Poster or Oral
Preview Disclosure
Travel Award: Yes
Publication of email address: Yes, joshi.avni@mayo.edu
I confirm that all authors listed on this abstract have knowledge of the abstract submission:
Yes
Title: Flu Vaccination in Asthmatics: Does It Work?
A. Y. Joshi, MD1, V. N. Iyer, MD,MPH1, M. F. Hartz, MD1, G. W. Volcheck, MD,Ph.D1, A. M. Patel,
MD1 and J. T. Li, MD,Ph.D1. 1Mayo Clinic College of Medicine, Rochester, MN.
INTRODUCTION: Influenza is known to be associated with asthma exacerbation but the
effectiveness of the trivalent inactivated flu vaccine (TIV) in asthmatics is unknown.

METHODS: We conducted a cohort study of all pediatric subjects( 6 months to 18 years age) who were evaluated at Mayo Clinic, Rochester, MN, USA who had laboratory confirmed influenza during each flu season from 1999-2006 to evaluate the efficacy of TIV. A case control analysis was performed with the cases and the controls being the subjects with asthma who did and did not required hospitalization with the influenza illness respectively.

RESULTS:
There were 236 subjects with laboratory confirmed influenza from 1996-2006.

In assessing the effectiveness of the TIV for preventing hospitalization with influenza in all subjects, there was an overall trend towards higher rates of hospitalization in subjects who got the TIV as compared to the ones who did not get the TIV( OR:2.97, CI: 1.3,6.7).Using Cochran-Mantel-Haenszel (CMH) test for Asthma status stratification, there was a significant association between hospitalization in asthmatic subjects and TIV (P=0.006).

http://www.call4abstracts.com/ats/society_admin/abs_preview.php?absnum=561 (1 of 2) [5/11/2009 1:43:56 PM]
http://www.call4abstracts.com/ats/society_admin/abs_preview.php?absnum=561
In the asthmatic subset:
There was no association between ER visit and receiving the TIV ,severity of asthma and the risk of hospitalization or the hospital length of stay and receiving the TIV.

In assessing access to medical care, there was no association between hospitalizations and health care insurance plans (Odds ratio:0.3, P= 0.13)

CONCLUSION:
1) TIV did not provide any protection against hospitalization in pediatric subjects' esp. children with asthma. On the contrary, we found a 3- fold increased risk of hospitalization in subjects who did get the TIV vaccine.This may be a reflection not only of the vaccine effectiveness but also the population of children who are more likely to get the vaccine.

2) More studies are needed to assess not only the immunogenicity but also efficacy of different influenza vaccines in asthmatic subjects.
http://

July 13, 2009

Mercury Containing Swine flu Vaccine May be Cleared After Five-Day Trial

In London, the Sunday Times is reporting that "When the new vaccine for swine flu arrives in Britain, regulators said this weekend, it could be approved for use in just five days."

No word yet on how long the trials for the H1N1 shots will last in the US.

I have spoken to an official at the Maine health department who is reporting that the vaccine delivered here will be one that comes in multidose vials, therefore will be a mercury containing vaccine.

Last week, HHS secretary Kathleen Sebelius said that HHS was "anticipating a voluntary" H1N1 vaccine program this fall, which leaves room for the possibility that HHS could change their minds and make it mandatory.

I would encourage everyone to keep an eye on this story as it develops, as hastily manufactured, tested and delivered vaccines that are not held up to the same scrutiny that is standard during FDA licensure certainly would have a greater potential for adverse reactions when introduced to the general public.

Swine flu vaccine to be cleared after five-day trial
July 12, 2009
The Sunday Times
byJon Ungoed-Thomas

The path of a popular medicine from the laboratory to the chemist or doctor’s surgery can involve years of clinical trials on a select group of patients.

When the new vaccine for swine flu arrives in Britain, regulators said this weekend, it could be approved for use in just five days.

Regulators at the European Medicines Agency (EMEA) said the fast-tracked procedure has involved clinical trials of a “mock-up” vaccine similar to the one that will be used for the biggest mass vaccination programme in generations. It will be introduced into the general population while regulators continue to carry out simultaneous clinical trials.

The first patients in the queue for the jab - being supplied to the UK by GSK and Baxter Healthcare - may understandably be a little nervous at any possible side effects. A mass vaccination campaign against swine flu in America was halted in the 1970s after some people suffered Guillain-Barré syndrome, a disorder of the nervous system.

However, regulators said fast-tracking would not be at the expense of patient safety. “The vaccines are authorised with a detailed risk management plan,” the EMEA said. “There is quite a body of evidence regarding safety on the trials of the mock-up, and the actual vaccine could be assessed in five days.”

The UK government has ordered enough vaccine to cover the entire population. GPs are being told to prepare for a nationwide vaccination campaign.

Dr Peter Holden, the British Medical Association’s lead negotiator on swine flu, who has been attending Department of Health meetings on the outbreak, said GPs’ surgeries were prepared for one of the biggest vaccination campaigns in almost 50 years.

He said although swine flu was not causing serious illness in patients, health officials were eager to start a mass vaccination campaign, starting first on priority groups. First, the jabs would reduce the chances of a shortage of hospital beds because of people suffering from swine flu. Second, it would reduce the effect on the economy by ensuring workers were protected from the virus.

“The high-risk groups will be done at GPs’ surgeries. People are still making decisions over this, but we want to get cracking before we get a second wave, which is traditionally far more virulent.”

Holden said it was likely the elderly would be given their seasonal flu jab as well as the swine flu vaccination. The new vaccine is likely to require two doses.

Details of the inoculation plans emerged after the death of a patient, reportedly a middle-aged man, at a hospital in the Basildon area of Essex. The victim had no underlying health problems, but officials say there is no evidence the swine flu virus had mutated into a more dangerous strain.

Holden said it would be the biggest campaign in response to an outbreak since mass vaccination against smallpox in 1962. He said surgeries would be aiming to inoculate about 30 people an hour in a “military-style operation”.

The Department of Health said it had still not finalised which groups would be vaccinated first, but children, frontline health workers, people with underlying illnesses and the elderly are likely to take priority.

The European Commission is also identifying population groups which it believes should get priority. It is keen to ensure that countries such as the UK, which had ordered supplies of the vaccine in advance, do not cause inequities in treatment elsewhere in Europe.

It warned health ministers in a note circulated last month that if the vaccines were more readily available in some countries it could cause “vaccine tourism/shopping in other member states”.

About 15 people have died of swine flu in Britain, but most of those infected get only mild symptoms. According to the latest figures from the Health Protection Agency, the UK has had 9,718 confirmed cases of the disease.

July 10, 2009

H1N1 Flu: Mike Wallace of 60 Minutes on the 1976 Swine Flu Vaccine Push

The Federal Government has begun the push of the swine flu vaccine, even before the vaccine has been completed.

It is more than a bit disconcerting to hear that the government is recommending a vaccine, and has decided to administer it in schools, before it has even been completed much less tested. The mantra of CDC on vaccines has always been, "the benefits outweigh the risks". Yet we have no vaccine or test upon which to base a risk/benefit analysis. This for a virus that appears to be less dangerous than the seasonal flu.

In 1976 CDC decided to launch a similar campaign. It was a disaster. Swine flu never came to fruition, and 4,000 people were permanently injured or killed by the shot.

In 1979, 60 Minutes did a story on the damage. It aired only once, but resurfaced last month on the internet.

It is obvious why it only aired once.

It is REMARKABLE how closely this story parallels our own. 30 years later, the CDC seems to have learned nothing about anticipating and dealing properly with vaccine injury. You could have taken these exact same quotes out of this story and put them in an autism story.

So did this exchange happen in 1979 or in 2009?:

Interviewer: "Why does this report from your own agency list neurological complications as a possibility?"

Director of CDC: "I think the consensus of the scientific community was that the evidence relating neurologic disorders to immunizations was such that they did not feel that this association was a real one."



The ads encouraging my parents to get the swine flu shot back then were not PSA's that took seriously their right to informed consent and educated them on the risks and benifits of getting the vaccine, they were PR pieces (including scare tactics, "...but Dotty had a heart condition and she died") put together by Madison Avenue.

Not only has HHS not learned to treat the public respectfully and be straight with them on this vaccine, they have lowered the bar on their PR push... all the way. This advertising push will be brought to you not by reasoned physicians upholding their ethical obligations by offering a comprehensive overview of risks and benifits, it will not even be brought to you by the professional ad men who sell you cars and beer, it will be brought to you by you:


Create a Flu Video & Be Eligible to Win $2500


So now you can not only be entertained by Fred Figglehorn, you can also get your medical advice from him.

HHS gets around these sticky ethical delemma's of being honest with the public and not trading on emotions or fears, by letting the public scare and cajole themselves into getting the shot.

As much as CDC claims that it wants to gain back credibility on vaccine issues, moves like this say different.

July 8, 2009

I Love Missouri Governor Jay Nixon


Congressional Briefing by Maloney on Vaxxed v. Unvaxxed Bill

Call your Senators and Representatives offices and ask them to attend:

Rep. Maloney and Rep. Smith To Host A Second Autism Congressional Briefing An Update On Federal Autism Research And Treatment Initiatives

PLEASE CONTACT YOUR US SENATORS (HERE) AND MEMBERS OF CONGRESS (HERE) AND URGE THEM TO ATTEND OR SEND A STAFF MEMBER TO THIS IMPORTANT AUTISM-VACCINE BRIEFING ON CAPITOL HILL

Friday, July 17 at 9:30 AM
210 Cannon House Office Building
Independence Avenue, Washington, DC.

FREE AND OPEN TO THE PUBLIC

Rep. Carolyn Maloney (D-NY) and Rep. Christopher Smith (R-NJ) is hosting a special briefing for Members of Congress and their Staff to discuss issues related to autism research and treatment. We hope that you will attend the briefing to learn about the changing dynamics of the autism debate, as you will find many in government and science believe this debate is far from settled.

David Kirby, investigative journalist and author of The New York Times bestseller Evidence of Harm, Mercury in Vaccines and the Autism Epidemic – A Medical Controversy, will inform Members and their staff about developments regarding environmental factors in autism and the “Seven Studies to Watch” – Plus, changing ASD demographics post-thimerosal reduction. Mr. Kirby will also be joined by Mark Blaxill, Editor-at-Large of Age of Autism, Director of the Coalition for SAFE MINDS and co-author of a forthcoming book on the roots of the autism epidemic, who will address the policy and public health implications of the autism crisis.
Among the issues to be discussed are:
  • The unanimous endorsement by the National Vaccine Advisory Committee to look at the feasibility of a large vaccinated-unvaccinated study, with autism as an outcome.

  • The NVAC endorsement of three other vaccine-autism investigations, including children with mitochondrial dysfunction, children with regressive autism, and vaccine injury as a risk factor for ASD.

  • Recent Vaccine Court decisions finding the MMR and Hep B vaccines caused injuries that led to autism and MS.

  • The NIH Early Autism Risk Longitudinal Investigations EARLI study and the HHS/EPA National Children’s Study, both of which are looking at vaccination and mercury exposures, with autism as a possible outcome.

  • The CDC’s Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) Network, whose five-year goal includes studying "specific mercury exposures, including any vaccine use by the mother during pregnancy and the child's vaccine exposures after birth.”

  • Cleveland Clinic – A recent article in PLoS Online by authors from the Cleveland Clinic, Harvard and Johns Hopkins University reported that, "Large, population-based studies will be needed to identify a possible relationship of vaccination with autistic regression in persons with mitochondrial dysfunction.”

  • Recent statements by Federal health officials such as Dr. Duane Alexander, Director of the Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD), who said it was “legitimate to ask” whether vaccines can trigger autism, and Dr. Anthony Fauci, Director of NIAID, who said in a US News and World report article, “we may want to screen everyone prior to vaccination (for) undetectable diseases like a subclinical mitochondrial disorder."

  • The U.C. Davis M.I.N.D. Institute study which found, that the seven- to eight-fold increase in the number children born in California with autism since 1990 cannot be explained by either changes in how the condition is diagnosed or counted — and the trend shows no sign of abating. This as young adults begin to flood the social services system

  • Reports of reduced Autism Spectrum Disorder (ASD) severity among the youngest children, following reduction of thimerosal in childhood vaccines.

Please contact your elected representatives and urge them to attend.
A RUNNING TALLY OF CONGRESSIONAL RSVPS WILL BE KEPT AT WWW.AGEOFAUTISM.COM,
IF YOU RECEIVE ANY REPLY FROM LAWMAKERS IN YOUR STATE, PLEASE FORWARD THAT INFORMATION TO kirbylecture@gmail.com

July 7, 2009

Babies Born with Genetal Malformations Increasing

Another screaming wake up call that is not being heard by the government health authorities.

Please consider bringing this New York Times column to the attention of your legislator and public health department.

Add that you would like them to get on board with the Environmental Working Group's Kid Safe Chemicals Act.

It’s Time to Learn From Frogs
By NICHOLAS D. KRISTOF
New York Times: June 27, 2009

Some of the first eerie signs of a potential health catastrophe came as bizarre deformities in water animals, often in their sexual organs.


Frogs, salamanders and other amphibians began to sprout extra legs. In heavily polluted Lake Apopka, one of the largest lakes in Florida, male alligators developed stunted genitals.

In the Potomac watershed near Washington, male smallmouth bass have rapidly transformed into “intersex fish” that display female characteristics. This was discovered only in 2003, but the latest survey found that more than 80 percent of the male smallmouth bass in the Potomac are producing eggs.

Now scientists are connecting the dots with evidence of increasing abnormalities among humans, particularly large increases in numbers of genital deformities among newborn boys. For example, up to 7 percent of boys are now born with undescended testicles, although this often self-corrects over time. And up to 1 percent of boys in the United States are now born with hypospadias, in which the urethra exits the penis improperly, such as at the base rather than the tip.

Apprehension is growing among many scientists that the cause of all this may be a class of chemicals called endocrine disruptors. They are very widely used in agriculture, industry and consumer products. Some also enter the water supply when estrogens in human urine — compounded when a woman is on the pill — pass through sewage systems and then through water treatment plants.

These endocrine disruptors have complex effects on the human body, particularly during fetal development of males.

“A lot of these compounds act as weak estrogen, so that’s why developing males — whether smallmouth bass or humans — tend to be more sensitive,” said Robert Lawrence, a professor of environmental health sciences at the Johns Hopkins Bloomberg School of Public Health. “It’s scary, very scary.”

The scientific case is still far from proven, as chemical companies emphasize, and the uncertainties for humans are vast. But there is accumulating evidence that male sperm count is dropping and that genital abnormalities in newborn boys are increasing. Some studies show correlations between these abnormalities and mothers who have greater exposure to these chemicals during pregnancy, through everything from hair spray to the water they drink.

Endocrine disruptors also affect females. It is now well established that DES, a synthetic estrogen given to many pregnant women from the 1930s to the 1970s to prevent miscarriages, caused abnormalities in the children. They seemed fine at birth, but girls born to those women have been more likely to develop misshaped sexual organs and cancer.

There is also some evidence from both humans and monkeys that endometriosis, a gynecological disorder, is linked to exposure to endocrine disruptors. Researchers also suspect that the disruptors can cause early puberty in girls.

A rush of new research has also tied endocrine disruptors to obesity, insulin resistance and diabetes, in both animals and humans. For example, mice exposed in utero even to low doses of endocrine disruptors appear normal at first but develop excess abdominal body fat as adults.

Among some scientists, there is real apprehension at the new findings — nothing is more terrifying than reading The Journal of Pediatric Urology — but there hasn’t been much public notice or government action.

This month, the Endocrine Society, an organization of scientists specializing in this field, issued a landmark 50-page statement. It should be a wake-up call.

“We present the evidence that endocrine disruptors have effects on male and female reproduction, breast development and cancer, prostate cancer, neuroendocrinology, thyroid, metabolism and obesity, and cardiovascular endocrinology,” the society declared.

“The rise in the incidence in obesity,” it added, “matches the rise in the use and distribution of industrial chemicals that may be playing a role in generation of obesity.”

The Environmental Protection Agency is moving toward screening endocrine disrupting chemicals, but at a glacial pace. For now, these chemicals continue to be widely used in agricultural pesticides and industrial compounds. Everybody is exposed.

“We should be concerned,” said Dr. Ted Schettler of the Science and Environmental Health Network. “This can influence brain development, sperm counts or susceptibility to cancer, even where the animal at birth seems perfectly normal.”

The most notorious example of water pollution occurred in 1969, when the Cuyahoga River in Ohio caught fire and helped shock America into adopting the Clean Water Act. Since then, complacency has taken hold.

Those deformed frogs and intersex fish — not to mention the growing number of deformities in newborn boys — should jolt us once again.

July 3, 2009

Maine CDC Autism Conference: How Do We Know What Autism IS NOT if We Do Not Know What Autism IS? by Jon Poling, MD, PhD

Maine CDC Autism Conference 2009
Looking Forward Beyond Vaccines: How Do We Know What Autism IS NOT if We Do Not Know What Autism IS? Followed by Q&A with other conference speakers.
Jon Poling, MD, PhD
Neurologist, Clinical Assistant Professor
Medical College of Georgia
Father of child with autism


Maine CDC Autism Conference: Genes and Environment, Developmental and Chronic: An Inclusive Approach to Autism Science by Martha Herbert, MD, PhD

Maine CDC Autism Conference 2009
Genes and Environment, Developmental and Chronic: An Inclusive Approach to Autism Science, followed by Q&A
Martha Herbert, MD, PhD
Pediatric Neurologist
Massachusetts General Hospital
Harvard Medical School



Next Session:
Looking Forward Beyond Vaccines: How Do We Know What Autism IS NOT if We Do Not Know What Autism IS? by Jon Poling, MD, PhD

Maine CDC Autism Conference: Kim Block of WGME Presents News Piece on Autism

Maine CDC Autism Conference 2009
Kim Block, reporter for WGME, presents a news piece on autism treatment






Next Session:
Genes and Environment, Developmental and Chronic: An Inclusive Approach to Autism Science by Martha Herbert, MD, PhD

Maine CDC Autism Conference: Gastrointestinal and Nutritional Co-Morbidities in Autism by Tim Buie, MD

Maine CDC Autism Conference 2009
Gastrointestinal and Nutritional Co-Morbidities in Autism, followed by Q&A
Tim Buie, MD
Pediatric Gastroenterologist
LADDERS Program, MassGeneral Hospital for Children
Harvard Medical School



Questions from the Audience



Next Session:
Kim Block from WGME presents news piece on Autism treatment.

Maine CDC Autism Conference: Autism 101

Maine CDC Autism Conference 2009
Autism 101, First signs and symptoms, Maine’s new screening tool, how and when to refer for specialized diagnostics, how a diagnosis is made, AAP Autism Toolkit, diagnostic and therapeutic services in Maine.
Introduction of Speakers by Dora Mills, MD, MPH




Autism 101
Early Identification and Autism Prevalence
Nancy Cronin, Coordinator of the PDD Systems Change Initiative




Autism 101
Common understanding of what children with autism look like
Mary Ellen Gellerstedt, MD
Developmental-Behavioral Pediatrician
Eastern Maine Medical Center




Autism 101
Screening for Autism Spectrum Disorders
Victoria Dalzell, MD
Developmental-Behavioral Pediatrics
Barbara Bush Children's Hospital
Maine Medical Center



Autism 101
Developmental Screening in the Office
Donald Burgess, MD, FAAP



Autism 101
Diagnostic and Medical Evaluation, Intervention and Office Visits for Children on the Autism Spectrum
Carol Hubbard, MD
Developmental-Behavioral Pediatrician
Maine Medical Center



Autism 101
Questions from the Audience




Next Session:
Gastrointestinal and Nutritional Co-Morbidities in Autism by Tim Buie, MD